Alnylam Pharmaceuticals Inc Note 1.000 9/1 shares owned by Goldman Sachs Group
Quarter-by-quarter ownership of Alnylam Pharmaceuticals Inc Note 1.000 9/1 shares owned by Goldman Sachs Group
from 13F filings
Historical chart of Goldman Sachs Group investment in Alnylam Pharmaceuticals Inc Note 1.000 9/1
Tip: Access up to 7 years of quarterly data
All positions including Alnylam Pharmaceuticals Inc Note 1.000 9/1 held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Alnylam Pharmaceuticals Inc Note 1.000 9/1 by Goldman Sachs Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-12-31 | $2.1M | 1.4M | 1.47 |
Top funds holding Alnylam Pharmaceuticals Inc Note 1.000 9/1
View all funds holding Alnylam Pharmaceuticals Inc Note 1.000 9/1